Title |
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial |
|---|---|
Involved |
Julie Kolwelter (Verfasser)
Dennis Kannenkeril (Verfasser) Peter Linz (Verfasser) Susanne Jung (Verfasser)
Armin Michael Nagel (Verfasser)
Agnes Bosch (Verfasser) Christian Ott (Verfasser) Peter Bramlage (Verfasser) Lisa Nöh (Verfasser) Mario Schiffer (Verfasser) Michael Uder (Verfasser) Stephan Achenbach (Verfasser) Roland E. Schmieder (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Clinical research in cardiology 26.10.2022, Seite 1-11 |
Published |
2022 |
Language |
|
Country |
|
Topic |
|
Subject |
Cardiology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2023011121133944068893 (URN) |
Record ID |
1277849765 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: